CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

Autor: Gamze Ayaz, Howard H. Yang, Young-Im Kim, Yu-Chou Tseng, Maxwell P. Lee, Navdeep Malik, Jing Huang, Wendy Dubois, Hualong Yan, Shunlin Jiang, Chengyu Liu
Rok vydání: 2021
Předmět:
Cancer Research
Transcription
Genetic

Carcinogenesis
QH426-470
medicine.disease_cause
Suppressor Genes
Lung and Intrathoracic Tumors
law.invention
Prostate cancer
Mice
0302 clinical medicine
law
Breast Tumors
Medicine and Health Sciences
Genes
Tumor Suppressor

Receptor
Notch3

Genetics (clinical)
Regulation of gene expression
0303 health sciences
Mutation
Prostate Cancer
Luciferase Assay
Prostate Diseases
Immunohistochemistry
Gene Expression Regulation
Neoplastic

Cell Transformation
Neoplastic

Bioassays and Physiological Analysis
Oncology
030220 oncology & carcinogenesis
Core Binding Factor Alpha 2 Subunit
Female
Research Article
Tumor Suppressor Genes
Urology
Breast Neoplasms
Biology
Research and Analysis Methods
Core Binding Factor beta Subunit
03 medical and health sciences
Breast cancer
Gene Types
Cell Line
Tumor

Breast Cancer
medicine
Genetics
Animals
Humans
Molecular Biology
Ecology
Evolution
Behavior and Systematics

030304 developmental biology
Cell Proliferation
Enzyme Assays
Cell growth
Cancer
Cancers and Neoplasms
Biology and Life Sciences
Tumor Protein p73
medicine.disease
Xenograft Model Antitumor Assays
Genitourinary Tract Tumors
Cancer research
Suppressor
Tumor Suppressor Protein p53
Biochemical Analysis
Zdroj: PLoS Genetics
PLoS Genetics, Vol 17, Iss 5, p e1009553 (2021)
ISSN: 1553-7404
Popis: The CBFB gene is frequently mutated in several types of solid tumors. Emerging evidence suggests that CBFB is a tumor suppressor in breast cancer. However, our understanding of the tumor suppressive function of CBFB remains incomplete. Here, we analyze genetic interactions between mutations of CBFB and other highly mutated genes in human breast cancer datasets and find that CBFB and TP53 mutations are mutually exclusive, suggesting a functional association between CBFB and p53. Integrated genomic studies reveal that TAp73 is a common transcriptional target of CBFB and p53. CBFB cooperates with p53 to maintain TAp73 expression, as either CBFB or p53 loss leads to TAp73 depletion. TAp73 re-expression abrogates the tumorigenic effect of CBFB deletion. Although TAp73 loss alone is insufficient for tumorigenesis, it enhances the tumorigenic effect of NOTCH3 overexpression, a downstream event of CBFB loss. Immunohistochemistry shows that p73 loss is coupled with higher proliferation in xenografts. Moreover, TAp73 loss-of-expression is a frequent event in human breast cancer tumors and cell lines. Together, our results significantly advance our understanding of the tumor suppressive functions of CBFB and reveal a mechanism underlying the communication between the two tumor suppressors CBFB and p53.
Author summary The success of precision medicine in oncology requires a detailed understanding of genetic alterations and the functional associations between them. Recent genome-wide sequencing studies found that breast, ovarian, and prostate tumors have frequent CBFB mutations. Emerging evidence suggests that CBFB is a tumor suppressor in breast tumors. However, our understanding of the tumor suppressive functions of CBFB remains fragmented. In this study, our genetic analyses of CBFB and TP53 mutations suggest that CBFB and p53 are functionally associated in breast tumors. By leveraging the rich knowledge of the tumor suppressive function of p53, we found that CBFB induces the expression of TAp73, a well-established mediator for the tumor suppressive function of p53. TAp73 re-expression inhibits the tumorigenicity of CBFB-deficient breast cells. In addition, TAp73 depletion drives breast tumorigenesis by cooperating with NOTCH3, a CBFB-repressed oncogene. Moreover, human breast tumors and cancer cell lines frequently lose the expression of TAp73. Together, our study gains a mechanistic understanding of the tumor suppressive functions of CBFB, reveals a functional association between CBFB and p53 in breast cancer, and has important implications in precision medicine for breast cancer.
Databáze: OpenAIRE